Rising blood disorder prevalence propels the U.S. to capture 90.3% market share in North America’s hematology analyzer market in 2022
New York, Oct. 25, 2023 (GLOBE NEWSWIRE) — The global market for hematology analyzers is poised for substantial growth, with a projected size of USD 2.20 billion by 2033, reflecting a steady CAGR of 4.8%. This growth is fueled by ongoing research and development efforts across various domains, including stem cell research, gene therapies, targeted therapies, blood disorders, thalassemia, and omics, driving rapid expansion throughout the forecast period.
The latest research study encompasses industry trends, pricing analysis, patent evaluations, conference and webinar materials, identification of key stakeholders, and an in-depth analysis of consumer buying behavior in the market. The market’s expansion is predominantly underpinned by the increasing number of blood donations, a rising incidence of blood disorders, and the continuous technological advancements in hematology analyzers and associated reagents.
Blood disorders have emerged as a global health concern, encompassing diverse causes and posing a significant mortality risk. These disorders, including anemia, blood cancers, hemorrhagic conditions, and bloodborne infections, impact millions of individuals across all age groups each year.
The COVID-19 pandemic has played a pivotal role in the industry’s growth, as the demand for hematology analyzers surged due to their essential role in assessing COVID-19, enhancing their adoption worldwide. This development is expected to propel the hematology analyzer market forward during the forecast period.
For more insights into the Market, Request a Sample of this Report – https://www.persistencemarketresearch.com/samples/16510
|Market Revenue 2023||US$ 1.37 Billion|
|Estimated Revenue 2023||US$ 2.20 Billion|
|Growth Rate – CAGR||4.8%|
|No. of Pages||297 Pages|
|Market Segmentation||By Product Type, By Modality, By End user, By Region|
|Regions Covered||North America, Latin America, Europe, Asia Pacific, Middle East & Africa|
|Companies Covered||SYSMEX CORPORATION, Abbott Laboratories, Beckman Coulter Inc, Siemens AG, Boule Diagnostics AB., Nihon Kohden Corporation, Mindray, HORIBA Ltd., Diatron`, Cellavision, Edan Instrumnets, Inc, SAMSUNG, Biosystems SA, F. Hoffmann-La Roche Ltd., Shenzhen Dymind Biotechnology Co. Ltd., PZ CORMAY SA, PixCell, Shenzhen Landwind Insdustry Co. Ltd.|
The hematology analyzers market is divided into key regions, including North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. North America currently claims the largest share of the overall market, and it is anticipated to maintain its dominant position in the foreseeable future.
In North America, the hematology analyzer market is set for steady growth. The United States, in particular, held a substantial 90.3% market share in the North American market in 2022. This significant market share is attributed to the increasing prevalence of anemia and the continued demand for complete blood count analysis as a routine diagnostic procedure, ensuring consistent utilization of hematology analyzer equipment.
For Customization or Any Other Queries, Get in Touch with Our Industry Experts at: https://www.persistencemarketresearch.com/request-customization/16510
Key Factors Driving Growth in the Hematology Analyzer Market?
Several key factors are fueling the demand for hematology analyzers in the market. These include a growing preference for automated hematology instruments, ongoing technological advancements, and the integration of basic flow-cytometry techniques into automated hematology analyzers.
The need for point-of-care hematology analyzers is on the rise, particularly in remote and underserved areas where access to centralized laboratories may be limited. Point-of-care analyzers allow for swift testing and on-the-spot diagnosis, facilitating prompt treatment decisions.
With the global population aging, there is an increased susceptibility to various chronic diseases that necessitate regular blood monitoring. As the elderly population expands, so does the demand for hematology analyzers, which serve as vital tools for diagnosing and managing conditions like cancer, cardiovascular diseases, and autoimmune disorders.
Key Questions Answered in the Report
What is the size of the Hematology Analyzers Market?
The Hematology Analyzers Market is projected to expand at a compound annual growth rate (CAGR) of 4.8%, reaching USD 2.20 billion by 2033.
What is the current market size for Hematology Analyzers?
The market size for Hematology Analyzers in 2023 is anticipated to reach USD 1.37 billion.
Which year serves as the base year for the hematology analyzer market report?
The base year for the hematology analyzer market report is 2022.
Who are some notable manufacturers in the hematology analyzer market?
Prominent players in the hematology analyzer market include SYSMEX CORPORATION, Abbott Laboratories, Beckman Coulter Inc, Siemens AG, Boule Diagnostics AB, Nihon Kohden Corporation, Mindray, HORIBA Ltd, Diatron, Cellavision, Edan Instruments Inc, SAMSUNG, Biosystems SA, F. Hoffmann-La Roche Ltd, Shenzhen Dymind Biotechnology Co. Ltd, PZ CORMAY SA, PixCell, Shenzhen Landwind Industry Co. Ltd, Rayto Life and Analytical Sciences Co. Ltd, and Shenzen Prokan Electronics Inc.
What are the key factors that the Hematology (CBC) Analyzers Market research is based on?
The Hematology (CBC) Analyzers Market research is grounded in factors such as product, modality, end-user, and region.
Challenges Faced in The Hematology Analyzers Market:
Regulatory Hurdles: Meeting the stringent regulatory requirements imposed by various health authorities in different regions is a complex challenge. Compliance with evolving standards, certifications, and quality control measures is necessary to ensure the safety and effectiveness of hematology analyzers.
Cost and Capital Constraints: The upfront cost of purchasing and installing hematology analyzers can be substantial. This can be a major challenge for smaller healthcare facilities, clinics, and laboratories with limited financial resources. Additionally, ongoing operational costs, including maintenance, reagents, and consumables, can strain budgets.
Technological Advancements: Hematology analyzers continually evolve with technological advancements. Manufacturers and healthcare providers must keep pace with these changes, which may necessitate regular training and investment in new equipment and software.
Maintenance and Calibration: Routine maintenance and calibration are essential to maintaining the accuracy and precision of hematology analyzers. Downtime during maintenance can disrupt laboratory operations, and the costs associated with maintenance can be substantial.
Data Management: Hematology analyzers generate vast amounts of data. Managing, storing, and securing this data, especially in large healthcare facilities, is a considerable challenge.
Supply Chain Vulnerabilities: Disruptions in the supply chain can impact the availability of reagents, consumables, and spare parts needed for hematology analyzers. This vulnerability was evident during the COVID-19 pandemic.
Emerging Diseases and Healthcare Challenges: The sudden emergence of new diseases and healthcare challenges, such as the COVID-19 pandemic, demands the quick adaptability of hematology analyzers to provide relevant diagnostics and support research efforts.
Access our all-inclusive report featuring a dynamic dashboard highlighting industry leaders, market influence, competition overview, and regional trends. Grab it now with exclusive discounts! https://www.persistencemarketresearch.com/checkout/16510
Market Recent Developments, Collaborations, and Acquisitions
The hematology analyzer market has witnessed several noteworthy developments, collaborations, and acquisitions in recent times that have significantly impacted the industry. Here are some of the latest highlights:
- Sysmex’s Acquisition of Inostics: Sysmex Corporation, a leading provider of hematology analyzers, acquired Inostics, a molecular diagnostics company specializing in liquid biopsy technologies. This strategic acquisition aims to bolster Sysmex’s capabilities in the field of oncology diagnostics, particularly in the area of liquid biopsy testing for cancer detection and monitoring.
- Beckman Coulter’s Collaboration with Illumina: Beckman Coulter Life Sciences, a prominent player in the hematology analyzer market, collaborated with Illumina, a genomics solutions company, to develop a next-generation sequencing (NGS) workflow for clinical oncology research. This partnership aims to advance the use of NGS in hematology applications, including leukemia and lymphoma testing.
- Siemens Healthineers’ Innovations in Hematology: Siemens Healthineers has been actively investing in innovations for its hematology analyzer portfolio. Their recent developments include advanced technologies like artificial intelligence (AI) and digital solutions to enhance blood cell analysis accuracy and efficiency. These innovations are designed to provide more comprehensive hematology diagnostics.
- Horiba Medical’s Expansion: Horiba Medical, a significant player in the hematology analyzer market, expanded its global presence through collaborations and acquisitions. They entered into collaborations with several hospitals and laboratories worldwide to further research and development efforts in hematology diagnostics.
- Roche’s Collaboration with Foundation Medicine: Roche, a major pharmaceutical and diagnostic company, collaborated with Foundation Medicine, a molecular information company. This collaboration focuses on integrating Foundation Medicine’s genomic profiling assays with Roche’s hematology portfolio, offering more personalized diagnostics and treatment options for blood-related disorders.
- Abbott’s Alere Acquisition: Abbott Laboratories acquired Alere, a global leader in rapid diagnostics, including hematology analyzers. This acquisition has expanded Abbott’s offerings in point-of-care testing, providing a broader range of diagnostic solutions in various healthcare settings.
About Persistence Market Research:
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.
Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies’/clients’ shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
USA – Canada Toll-Free: 800-961-0353
Email: [email protected]
Originally published at https://www.einpresswire.com/article/664051056/hematology-analyzers-market-poised-to-reach-2-20-billion-by-2033-amid-rising-pediatric-blood-disorder-cases-and-continuous-innovation-report-by